← Evidence map

TrialIndian heart journal

Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study.

Gurpreet S Wander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38871219